SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: William Partmann who wrote (412)7/7/1999 8:05:00 AM
From: Henry Niman  Read Replies (1) of 10345
 
Today's Heard on the Street column in the WSJ focuses on SEC investigation of ELN's "aggressive" accounting practices. Story is being extensively reported on CNBC.

LGND Morphelan deal is noted prominently (only example given). LGND is a "small but fast growing company with 1Q '99 revenues of $10.3 Million".

A synopsis of the article is linked to the WSJ/DJ Synopsi table and CNBC Specials table at
pharmacognizance.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News